EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Circulating CTRP9 and aortic valve calcification jointly predict coronary artery calcification in coronary heart disease patients

Yanru Duan, Xiaoxue Jin, Yanan Ma, Wei Sun, Lei Nie, Shizhen Zhang, Rui Lu, Wei Cui, Guoqiang Gu, Yunhui Du, Demin Liu

Frontiers in Nutrition · 29.04.2026 · 13

DOI: 10.3389/fnut.2026.1783380 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Nutrition, online erschienen am 29.04.2026. Verfasst von Yanru Duan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing, China. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Vascular calcification predicts adverse cardiovascular outcomes. CTRP9, an adiponectin paralog, has vascular protective effects. We evaluated the association of circulating CTRP9 with aortic valve calcification (AVC) and coronary artery calcification (CAC) in a cross-sectional observational study.

Methods

Nine hundred coronary heart disease patients underwent echocardiography and optical coherence tomography; serum CTRP9 was measured in a subset. Logistic regression identified CAC determinants. ROC analysis assessed CTRP9 alone and combined with AVC for predicting severe CAC. AVC was modeled in ApoE−/− mice fed a Western diet for 24 weeks, with calcification markers analyzed via PCR and Western blot.

Results

CTRP9 independently protected against CAC (OR = 0.156, 95% CI: 0.11–0.21, p < 0.05). CTRP9 predicted CAC severity (AUC = 0.74), and combining it with AVC improved prediction of severe CAC (AUC = 0.843). Kendall’s Tau-b indicated strong correlation between severe AVC and CAC (τb = 0.597, p < 0.001). Exogenous CTRP9 attenuated aortic valve calcification in mice.

Conclusion

Lower CTRP9 levels associate with advanced AVC and greater CAC severity. Combining CTRP9 with AVC enhances risk prediction, highlighting CTRP9 as a potential biomarker and therapeutic target in vascular calcification.

Schlagwörter

Stichwörter der Autor:innen

C1q/tumor necrosis factor-related protein 9aortic valve calcificationbiomarkercardiovascular diseasecoronary artery calcification

Autor:innen und Institutionen

  • Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing, China.
  • Department of Cardiology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
  • Key Laboratory of Medical Biotechnology of Hebei Province, Shijiazhuang, China.

Zitieren

APA

Duan, Y., Jin, X., Ma, Y., Sun, W., Nie, L., Zhang, S., Lu, R., Cui, W., Gu, G., Du, Y., & Liu, D. (2026). Circulating CTRP9 and aortic valve calcification jointly predict coronary artery calcification in coronary heart disease patients. Frontiers in Nutrition, 13. https://doi.org/10.3389/fnut.2026.1783380

Vancouver

Duan Y, Jin X, Ma Y, Sun W, Nie L, Zhang S, et al. Circulating CTRP9 and aortic valve calcification jointly predict coronary artery calcification in coronary heart disease patients. Frontiers in Nutrition. 2026;13. doi:10.3389/fnut.2026.1783380

BibTeX
@article{Duan2026,
  author = {Duan, Yanru and Jin, Xiaoxue and Ma, Yanan and Sun, Wei and Nie, Lei and Zhang, Shizhen and Lu, Rui and Cui, Wei and Gu, Guoqiang and Du, Yunhui and Liu, Demin},
  title = {Circulating CTRP9 and aortic valve calcification jointly predict coronary artery calcification in coronary heart disease patients},
  journal = {Frontiers in Nutrition},
  year = {2026},
  volume = {13},
  doi = {10.3389/fnut.2026.1783380}
}
Kostenlos starten →